Mauritania vs Tunisia: Antiretroviral therapy coverage for PMTCT
Mauritania
39.0%
in 2024
Tunisia
32.0%
in 2024
Mauritania rank
73rd
Tunisia rank
75th
Antiretroviral therapy coverage for PMTCT over time
- Mauritania
- Tunisia
How they compare
Mauritania currently reports 39.0% against 32.0% in Tunisia, a difference of 7.0%.
That makes Mauritania's figure about 1.2 times Tunisia's.
The two have swapped places 5 times across 25 shared years of data; in 2000 it was Tunisia ahead.
Mauritania ranks 73rd and Tunisia ranks 75th of 84 countries.
Across the 3 decades both report, Mauritania averaged higher in 2 and Tunisia in 1.
Head to head by decade
| Decade | Mauritania | Tunisia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.0% | 1.7% | 0.3% | Mauritania |
| 2010s | 25.1% | 15.5% | 9.6% | Mauritania |
| 2020s | 28.4% | 34.4% | 6.0% | Tunisia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Mauritania or Tunisia?
- Mauritania, at 39.0% against 32.0% in Tunisia as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Mauritania and Tunisia?
- 7.0%, with Mauritania ahead.
- How many years of comparable data are there for Mauritania and Tunisia?
- 25 years are reported by both, from 2000 to 2024.
- How do Mauritania and Tunisia rank globally for antiretroviral therapy coverage for pmtct?
- Mauritania ranks 73rd and Tunisia ranks 75th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).